Literature DB >> 2981405

Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors.

A S Maisel, H J Motulsky, P A Insel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981405     DOI: 10.1056/NEJM198501173120308

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Effect of calcium entry blockers on blood pressure and vasoconstrictor responses to alpha-1 adrenoceptor stimulation in conscious spontaneously hypertensive rats.

Authors:  M J Thoolen; C R Miller; A T Chiu; P B Timmermans
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 2.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 3.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 4.  Antiarrhythmic agents: drug interactions of clinical significance.

Authors:  T C Trujillo; P E Nolan
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 5.  Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.

Authors:  R N Brogden; P Benfield
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

Review 6.  Calcium antagonists in the elderly. A risk-benefit analysis.

Authors:  J B Schwartz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 7.  Cluster headache: from treatment to pathophysiology.

Authors:  Gennaro Bussone
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 8.  Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

9.  Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

Authors:  C R Jones; F Pasanisi; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

10.  Quinidine-induced potentiation of cardiovascular effects of nitrendipine: functional aspects and possible molecular mechanisms.

Authors:  S Herzig; J Jischa; A Beinhauer; B Geirhos; K Tacke; R G Hempelmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.